Ligand validation:5HUM

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 5HUM designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5HUM_NAG_A_502	99%	27%	0.054	0.981	1.37	1.58	2	3	2	0	100%	0.9333
5HUM_NAG_B_503	98%	71%	0.053	0.979	0.51	0.59	-	-	0	0	100%	0.9333
5HUM_NAG_A_503	98%	62%	0.052	0.977	0.78	0.67	1	-	0	0	100%	0.9333
5HUM_NAG_D_502	98%	65%	0.055	0.976	0.53	0.82	-	-	0	0	100%	0.9333
5HUM_NAG_C_502	97%	55%	0.057	0.972	0.58	1.14	-	1	0	0	100%	0.9333
5HUM_NAG_B_502	97%	77%	0.061	0.974	0.34	0.56	-	-	0	0	100%	0.9333
5HUM_NAG_C_503	97%	60%	0.061	0.974	0.6	0.93	-	1	1	0	100%	0.9333
5HUM_NAG_D_503	96%	64%	0.063	0.974	0.65	0.72	-	-	0	0	100%	0.9333
6HFY_NAG_C_501	72%	20%	0.114	0.939	1.15	2.22	2	5	0	0	100%	0.9333
6HG5_NAG_A_501	64%	31%	0.11	0.909	1.29	1.44	1	2	0	0	100%	0.9333
1V0Z_NAG_C_506	63%	54%	0.127	0.933	0.67	1.11	-	1	5	0	93%	0.9333
1W1X_NAG_A_1485	55%	66%	0.137	0.905	0.27	1.01	-	1	2	0	100%	0.9333
2CML_NAG_B_2480	51%	7%	0.164	0.918	2.31	2.53	1	6	5	1	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.